US Patent Issued to RISE BIOPHARMACEUTICALS on Feb. 18 for "Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drug" (Taiwanese Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,454, issued on Feb. 18, was assigned to RISE BIOPHARMACEUTICALS INC. (Beijing).

"Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drug" was invented by Jya-Wei Cheng (Tainan, Taiwan), Hsi-Tsung Cheng (Tainan, Taiwan), Hui-Yuan Yu (Tainan, Taiwan) and Su-Ya Hsu (Tainan, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel modified chemokine peptide. The novel modified chemokine peptide can be combined with a targeted drug for treating cancer, especially for treating drug-resistant cancer, and inhibiting tumor growth more effectively." ...